Strategic AgreementStrategic Agreement • September 5th, 2021
Contract Type FiledSeptember 5th, 2021This Agreement reflects the common intention of the Commonwealth and GBMA that Australians have access to the right medicines when they need them. The parties agree that this access is underpinned by secure medicines supply delivered at an efficient cost to the Australian taxpayer. The generic and biosimilar medicines industry is key to the achievement of these objectives as integral suppliers of life saving and life changing medicines in Australia subsidised through the Pharmaceutical Benefits Scheme (PBS).